| 1,25(OH)2D3 | 1,25-dihydroxyvitamin D3 (calcitriol) |
| 2-HG | 2-hydroxyglutarate |
| 25(OH)D | 25-hydroxyvitamin D |
| 5hmC | 5-hydroxymethylcytosine |
| 5mC | 5-methylcytosine |
| ABC | ATP-binding cassette |
| ACE | angiotensin-converting enzyme |
| AKT | protein kinase B |
| ALL | acute lymphoblastic leukemia |
| ALOX5 | arachidonate 5-lipoxygenase |
| α-KG | alpha-ketoglutarate |
| ALT | alanine aminotransferase |
| AMPK | AMP-activated protein kinase |
| Apaf-1 | apoptotic protease-activating factor 1 |
| ARE | antioxidant response element |
| ASC | apoptosis-associated speck-like protein containing a CARD |
| ACMSD | α-amino-β-carboxy-muconate-semialdehyde decarboxylase |
| AST | aspartate aminotransferase |
| ATG5 | autophagy-related protein 5 |
| ATM | ataxia–telangiectasia mutated |
| ATP | adenosine triphosphate |
| BAK | BCL-2 antagonist/killer 1 |
| BAX | BCL-2-associated X protein |
| BCL-2 | B-cell lymphoma 2 |
| Bcl-xL | B-cell lymphoma-extra large |
| BCRP | breast cancer resistance protein |
| Bmi-1 | BMI1 proto-oncogene, polycomb ring finger |
| BNP | B-type natriuretic peptide |
| BTG2 | B-cell translocation gene 2 |
| CARD | caspase activation and recruitment domain |
| CCSS | Childhood Cancer Survivor Study |
| CDK1 | cyclin-dependent kinase 1 |
| CGI(s) | CpG island(s) |
| CHKB-DT | choline kinase beta divergent transcript |
| circRNA(s) | circular RNA(s) |
| CK | creatine kinase |
| CK-MB | creatine kinase-MB isoenzyme |
| CoA | coenzyme A |
| CoQ10 | coenzyme Q10 |
| CpG | cytosine–phosphate–guanine dinucleotide |
| CpH | non-CpG cytosine context in which H denotes A, C, or T |
| cTnT | cardiac troponin T |
| Cyt c | cytochrome c |
| DHA | docosahexaenoic acid |
| DLBCL | diffuse large B-cell lymphoma |
| DMS | differentially methylated sites |
| DNA | deoxyribonucleic acid |
| DNMT(s) | DNA methyltransferase(s) |
| DNMT1 | DNA methyltransferase 1 |
| DNMT3A | DNA methyltransferase 3 alpha |
| DNMT3B | DNA methyltransferase 3 beta |
| DOX | doxorubicin |
| Drp1 | dynamin-related protein 1 |
| EDTA | ethylenediaminetetraacetic acid |
| EGCG | epigallocatechin-3-gallate |
| EGFR | epidermal growth factor receptor |
| EndMT | endothelial-to-mesenchymal transition |
| EPA | eicosapentaenoic acid |
| ERK1/2 | extracellular signal-regulated kinases 1 and 2 |
| ETC | electron transport chain |
| ETS | electron transport system |
| Fas | Fas cell surface death receptor |
| FasL | Fas ligand |
| FDA | US Food and Drug Administration |
| Fis1 | mitochondrial fission protein 1 |
| FMT | fecal microbiota transplantation |
| Fn14 | fibroblast growth factor-inducible 14 |
| γH2AX | phosphorylated histone H2AX |
| GCLC | glutamate–cysteine ligase catalytic subunit |
| GCLM | glutamate–cysteine ligase modifier subunit |
| GLS | global longitudinal strain |
| GPx | glutathione peroxidase |
| GPX4 | glutathione peroxidase 4 |
| GSDMD | gasdermin D |
| GSH | glutathione |
| H2AK119Ub | monoubiquitination of histone H2A at lysine 119 |
| H2AX | histone H2A variant X |
| H3K27ac | acetylation of histone H3 lysine 27 |
| H3K27me3 | trimethylation of histone H3 lysine 27 |
| H3K4 | histone H3 lysine 4 |
| H3K4me1 | monomethylation of histone H3 lysine 4 |
| H3K4me3 | trimethylation of histone H3 lysine 4 |
| H9c2 | rat embryonic cardiomyoblast cell line |
| HAT(s) | histone acetyltransferase(s) |
| HAX-1 | HCLS1-associated protein X-1 |
| HCM-ls | human cardiomyocyte-like cells |
| HDAC(s) | histone deacetylase(s) |
| HDM(s) | histone demethylase(s) |
| HER2 | human epidermal growth factor receptor 2 |
| HF | heart failure |
| HINT2 | histidine triad nucleotide-binding protein 2 |
| HM(s) | histone modification(s) |
| HMT(s) | histone methyltransferase(s) |
| HO-1 | heme oxygenase-1 |
| HUVEC(s) | human umbilical vein endothelial cell(s) |
| ICAM-1 | intercellular adhesion molecule-1 |
| IDH | isocitrate dehydrogenase(s) |
| IDO1 | indoleamine 2,3-dioxygenase 1 |
| IGF-1 | insulin-like growth factor 1 |
| IL | interleukin |
| iNOS | inducible nitric oxide synthase |
| JMJD3 | Jumonji domain-containing protein 3 |
| JNK | c-Jun N-terminal kinase |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LC3I/II | microtubule-associated protein 1 light chain 3 I/II |
| LDH | lactate dehydrogenase |
| LGE | late gadolinium enhancement |
| lncRNA(s) | long non-coding RNA(s) |
| LPS | lipopolysaccharide |
| LVEF | left ventricular ejection fraction |
| MAPK(s) | mitogen-activated protein kinase(s) |
| MCM-41 | Mobil Composition of Matter No. 41 |
| MCP-1 | monocyte chemoattractant protein-1 |
| mCpH | methylated CpH |
| MDA | malondialdehyde |
| MeCP2 | methyl-CpG-binding protein 2 |
| Mfn2 | mitofusin 2 |
| miR/miRNA(s) | microRNA(s) |
| MitoQ | mitoquinone |
| MnSOD | manganese superoxide dismutase |
| mPTP | mitochondrial permeability transition pore |
| MRI | magnetic resonance imaging |
| mRNA(s) | messenger RNA(s) |
| MRP1 | multidrug resistance-associated protein 1 |
| mtDNA | mitochondrial DNA |
| mTOR | mechanistic target of rapamycin |
| mTORC1 | mechanistic target of rapamycin complex 1 |
| NAC | N-acetylcysteine |
| NAD+ | nicotinamide adenine dinucleotide |
| NADPH | reduced nicotinamide adenine dinucleotide phosphate |
| ncRNA(s) | non-coding RNA(s) |
| NF-κB | nuclear factor kappa B |
| NLRP3 | NLR family pyrin domain-containing 3 |
| NO | nitric oxide |
| NORAD | non-coding RNA activated by DNA damage |
| NOX4 | NADPH oxidase 4 |
| NQO1 | NAD(P)H quinone oxidoreductase 1 |
| NRF1/2 | nuclear respiratory factors 1 and 2 |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| OPA1 | optic atrophy 1 |
| OS | oxidative stress |
| p21 | cyclin-dependent kinase inhibitor 1A |
| p53 | tumor protein p53 |
| PAGln | phenylacetylglutamine |
| PGC-1α | peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PI3K | phosphoinositide 3-kinase |
| PINK1 | PTEN-induced kinase 1 |
| piRNA(s) | PIWI-interacting RNA(s) |
| PTM(s) | post-translational modification(s) |
| PTPN2 | protein tyrosine phosphatase non-receptor type 2 |
| PUFA(s) | polyunsaturated fatty acid(s) |
| QPRT | quinolinate phosphoribosyltransferase |
| Rac1 | Ras-related C3 botulinum toxin substrate 1 |
| Res-SLN | resveratrol-loaded solid lipid nanoparticles |
| RNA | ribonucleic acid |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| rRNA(s) | ribosomal RNA(s) |
| SAM | S-adenosylmethionine |
| SCFA(s) | short-chain fatty acid(s) |
| Se@CM | selenium-enriched Cordyceps militaris-based oral microcarrier |
| SERCA | sarco/endoplasmic reticulum Ca2+-ATPase |
| SESN2 | sestrin 2 |
| SGK1 | serum/glucocorticoid-regulated kinase 1 |
| siRNA(s) | small interfering RNA(s) |
| SIRT(s) | sirtuin(s) |
| SJLIFE | St. Jude Lifetime Cohort Study |
| SKQ1 | mitochondria-targeted plastoquinone derivative |
| sncRNA(s) | small non-coding RNA(s) |
| snoRNA(s) | small nucleolar RNA(s) |
| snRNA(s) | small nuclear RNA(s) |
| SOD | superoxide dismutase |
| STAT | signal transducer and activator of transcription |
| TET(s) | ten-eleven translocation enzyme(s) |
| TET1 | ten-eleven translocation methylcytosine dioxygenase 1 |
| TET2 | ten-eleven translocation methylcytosine dioxygenase 2 |
| TET3 | ten-eleven translocation methylcytosine dioxygenase 3 |
| TF(s) | transcription factor(s) |
| TFAM | mitochondrial transcription factor A |
| TFEB | transcription factor EB |
| TGF-β | transforming growth factor beta |
| TINCR | terminal differentiation-induced non-coding RNA |
| TNF-α | tumor necrosis factor alpha |
| TOP2α | topoisomerase II alpha |
| TOP2β | topoisomerase II beta |
| TPGS | D-α-tocopheryl polyethylene glycol 1000 succinate |
| tRNA(s) | transfer RNA(s) |
| TUNEL | terminal deoxynucleotidyl transferase dUTP nick-end labeling |
| TWEAK | TNF-like weak inducer of apoptosis |
| TXNRD | thioredoxin reductase |
| VC/VK3 | ascorbate and menadione sodium bisulfite |
| VCAM-1 | vascular cell adhesion molecule-1 |
| VDR | vitamin D receptor |
| Xc− | cystine/glutamate antiporter system Xc− |
| YAP | Yes-associated protein |
| ZO-1 | zonula occludens-1 |